Package 68071-3573-4

{"route": ["ORAL"], "spl_id": "2ad1146a-8d11-264f-e063-6394a90a92b5", "openfda": {"nui": ["N0000020060", "N0000180187", "N0000180188", "N0000175468", "N0000175459"], "upc": ["0368071357349"], "unii": ["X4HES1O11F"], "rxcui": ["197311"], "spl_set_id": ["116f4f0d-66c5-49dd-e063-6394a90ab2b5"], "pharm_class_epc": ["Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"], "pharm_class_moa": ["DNA Polymerase Inhibitors [MoA]"], "manufacturer_name": ["NuCare Pharmaceuticals,Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "4 TABLET in 1 BOTTLE (68071-3573-4)", "package_ndc": "68071-3573-4", "marketing_start_date": "20240215"}], "brand_name": "Acyclovir", "product_id": "68071-3573_2ad1146a-8d11-264f-e063-6394a90a92b5", "dosage_form": "TABLET", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "68071-3573", "generic_name": "Acyclovir", "labeler_name": "NuCare Pharmaceuticals,Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Acyclovir", "active_ingredients": [{"name": "ACYCLOVIR", "strength": "400 mg/1"}], "application_number": "ANDA209366", "marketing_category": "ANDA", "marketing_start_date": "20200815", "listing_expiration_date": "20261231"}